As India firmly establishes Hyderabad as the world’s centre of vaccines, Biological E has disclosed its development plans for vaccine manufacturing with a total investment of more than 1,800 crore.
The main goals of the expansion include boosting vaccine manufacturing as well as R&D and generic injectables.
The announcement was made by industries and IT minister KT Rama Rao during a meeting with Biological E’s managing director Mahima Datla.
Rao says, “I am delighted to announce the expansion plans of Biological E in Genome Valley. Hyderabad is already known as the ‘Vaccine Capital of the World’ and this expansion further accelerates our strength to serve the world with life-saving vaccines”. Managing Director, Biological E, Datla adds, “I am thankful to the government of Telangana, the vision of Chief Minister K Chandrashekar Rao and Rama Rao for spearheading and continuing to facilitate in a way that enables us to take quick decisions to expand even during the pandemic times”.
